Itraconazole oral solution

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), F2G Biotech GmbH

Conditions

AspergillosisHealthyLung Diseases, Fungal

Phase 1

Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim

CompletedNCT04171739

F2G Biotech GmbHHealthy

Start: 2019-11-18End: 2020-02-11Updated: 2020-07-24

Phase 2

A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma

CompletedNCT00005668

National Institute of Allergy and Infectious Diseases (NIAID)Aspergillosis, Lung Diseases, Fungal

End: 2005-11-30Target: 96Updated: 2010-08-27